In vivo non-invasive monitoring of dystrophin correction in a new Duchenne muscular dystrophy reporter mouse

L Amoasii, H Li, Y Zhang, YL Min… - Nature …, 2019 - nature.com
Duchenne muscular dystrophy (DMD) is a fatal genetic disorder caused by mutations in the
dystrophin gene. To enable the non-invasive analysis of DMD gene correction strategies in …

Gene editing restores dystrophin expression in a canine model of Duchenne muscular dystrophy

L Amoasii, JCW Hildyard, H Li, E Sanchez-Ortiz… - Science, 2018 - science.org
Mutations in the gene encoding dystrophin, a protein that maintains muscle integrity and
function, cause Duchenne muscular dystrophy (DMD). The deltaE50-MD dog model of DMD …

Precise correction of Duchenne muscular dystrophy exon deletion mutations by base and prime editing

F Chemello, AC Chai, H Li, C Rodriguez-Caycedo… - Science …, 2021 - science.org
Duchenne muscular dystrophy (DMD) is a fatal muscle disease caused by the lack of
dystrophin, which maintains muscle membrane integrity. We used an adenine base editor …

Prevention of muscular dystrophy in mice by CRISPR/Cas9–mediated editing of germline DNA

C Long, JR McAnally, JM Shelton, AA Mireault… - Science, 2014 - science.org
Duchenne muscular dystrophy (DMD) is an inherited X-linked disease caused by mutations
in the gene encoding dystrophin, a protein required for muscle fiber integrity. DMD is …

CRISPR/Cas9-mediated genome editing corrects dystrophin mutation in skeletal muscle stem cells in a mouse model of muscle dystrophy

P Zhu, F Wu, J Mosenson, H Zhang, TC He… - … Therapy-Nucleic Acids, 2017 - cell.com
Muscle stem cells (MuSCs) hold great therapeutic potential for muscle genetic disorders,
such as Duchenne muscular dystrophy (DMD). The CRISP/Cas9-based genome editing is a …

[HTML][HTML] Cellular reprogramming, genome editing, and alternative CRISPR Cas9 technologies for precise gene therapy of Duchenne muscular dystrophy

P Gee, H Xu, A Hotta - Stem cells international, 2017 - hindawi.com
In the past decade, the development of two innovative technologies, namely, induced
pluripotent stem cells (iPSCs) and the CRISPR Cas9 system, has enabled researchers to …

Single-swap editing for the correction of common Duchenne muscular dystrophy mutations

AC Chai, F Chemello, H Li, T Nishiyama, K Chen… - … Therapy-Nucleic Acids, 2023 - cell.com
Duchenne muscular dystrophy (DMD) is a fatal X-linked recessive disease of progressive
muscle weakness and wasting caused by the absence of dystrophin protein. Current gene …

CRISPR correction of Duchenne muscular dystrophy

YL Min, R Bassel-Duby, EN Olson - Annual review of medicine, 2019 - annualreviews.org
The ability to efficiently modify the genome using CRISPR technology has rapidly
revolutionized biology and genetics and will soon transform medicine. Duchenne muscular …

Adenoviral vectors encoding CRISPR/Cas9 multiplexes rescue dystrophin synthesis in unselected populations of DMD muscle cells

I Maggio, J Liu, JM Janssen, X Chen… - Scientific reports, 2016 - nature.com
Mutations disrupting the reading frame of the~ 2.4 Mb dystrophin-encoding DMD gene
cause a fatal X-linked muscle-wasting disorder called Duchenne muscular dystrophy (DMD) …

Efficient restoration of the dystrophin gene reading frame and protein structure in DMD myoblasts using the CinDel method

JP Iyombe-Engembe, DL Ouellet, X Barbeau… - … Therapy-Nucleic Acids, 2016 - cell.com
The CRISPR/Cas9 system is a great revolution in biology. This technology allows the
modification of genes in vitro and in vivo in a wide variety of living organisms. In most …